Home›Compare›Lttl vs Pallas Health

Lttl vs Pallas Health: Which Is Better?

Head-to-head comparison of Lttl and Pallas Health based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Lttl scores higher overall in our independent evaluation (66.2/100 vs 65.7/100), leading on value, experience, reputation. Pallas Health comes out ahead on trust & safety, product range. Pallas Health has the lower entry price (from $60/mo vs $79/mo), so the better value depends on which treatment you need.

66
Lttl
Good

Lttl is a 2026-launched telehealth brand selling compounded GLP-1s, microdosed GLP-1s and a wide menu of longevity compounds at flat, dose-independent prices.

Visit Lttl

Pallas Health is a July 2026-launched telehealth platform offering compounded and branded GLP-1s, longevity peptides, women's HRT, ED and prescription skincare, with unusually detailed compliance disclosures.

Visit Pallas Health

Score Breakdown

DimensionLttlPallas Health
Overall Score66.2/100 ✓65.7/100
Trust & Safety30%60/10066/100 ✓
Value25%80/100 ✓70/100
Experience20%62/100 ✓58/100
Product Range15%72/10080/100 ✓
Reputation10%50/100 ✓48/100

At a Glance

Founded20262026
HeadquartersWoodland Hills, CANewark, DE
Publicly tradedNoNo
Treatment categories26
Treatments listed1012
Starting price$79/mo$60/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryLttlPallas Health
Weight Loss / GLP-1$89
Compounded Semaglutide
$159–$239
Compounded Semaglutide (injectable)
Longevity & Peptides$79
Glutathione
$139–$199
NAD+

Lttl

+Among the lowest advertised compounded GLP-1 prices reviewed: semaglutide from $89/mo, tirzepatide from $139/mo, same price at every dose
+No membership fee, month-to-month plans, free expedited shipping
+Wide longevity menu (NAD+ in three formats, sermorelin, glutathione, MIC-B12, methylene blue, L-carnitine) alongside microdosed GLP-1s
−Launched in 2026, with about 10 Trustpilot reviews, all 5-star: too few to judge service quality
−Marketing claims such as 'trusted by 100k+ Americans' and a 'Best Provider of 2026' badge are hard to reconcile with the brand's age
−'Plans start at' pricing is shown next to an 'up to $140 off your first month' banner, so the ongoing price after the first month is unclear
Read the full Lttl review →

Pallas Health

+Detailed clinical-disclosure page names the operating entity, provider network (Lion MD), dispensing pharmacies and state-by-state visit rules
+Prices published for every product, including branded options (Wegovy pill, Foundayo, pens at cash rates)
+Broad catalog for a new entrant: compounded and branded GLP-1s, NAD+, sermorelin, glutathione, women's HRT, ED and prescription skincare
−Launched July 2026 with no public patient reviews, so service quality is unproven
−Billed every 4 weeks (13 charges a year); the $239 semaglutide renewal is well above the $139 first month
−A real-time video visit is required in 7 states plus DC, which adds friction for those patients
Read the full Pallas Health review →

Lttl vs Pallas Health — FAQ

Is Lttl better than Pallas Health?

▾

Lttl scores higher overall in our independent evaluation (66.2/100 vs 65.7/100), leading on value, experience, reputation. Pallas Health comes out ahead on trust & safety, product range. Pallas Health has the lower entry price (from $60/mo vs $79/mo), so the better value depends on which treatment you need.

Is Lttl or Pallas Health cheaper?

▾

Pallas Health has the lower starting price (from $60/mo vs $79/mo for Lttl). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Lttl and Pallas Health both offer?

▾

Both platforms treat Weight Loss / GLP-1, Longevity & Peptides. Lttl covers 2 treatment categories total and Pallas Health covers 6.

Still deciding?